--- title: "VIVOS INC (RDGL) stock listing, news and investor profile" url: "https://aibio.space/companies/vivos/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "VIVOS INC (OTC: RDGL), United States. Listing facts, related biotech companies and news on aibio.space." --- RDGL VIVOS INC OTC · United States # VIVOS INC (RDGL) news VIVOS INC is a public biotech or pharmaceutical company listed on OTC under the ticker RDGL, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest VIVOS INC news We have not published a story on VIVOS INC yet. When there is news, it will appear here. ## VIVOS INC at a glance - **Ticker**: RDGL - **Listing**: OTC - **Country**: United States - **Cash, Mar 31, 2025**: $3.3 million ### Related companies - [Neuronetics](https://aibio.space/companies/neuronetics/) NASDAQ: STIM - [Cadre Holdings](https://aibio.space/companies/cadre/) NYSE: CDRE - [ALIGN TECHNOLOGY INC](https://aibio.space/companies/align-technology/) NASDAQ: ALGN - [Functional Brands](https://aibio.space/companies/functional-brands/) OTC: MEHA - [Target Group](https://aibio.space/companies/target/) OTC: CBDY - [AtriCure](https://aibio.space/companies/atricure/) NASDAQ: ATRC - [Quantum Cyber](https://aibio.space/companies/quantum-cyber-n-v/) NASDAQ: QUCY - [HST Global](https://aibio.space/companies/hst-global/) OTC: HSTC ### Also on OTC - [CNBX Pharmaceuticals](https://aibio.space/companies/cnbx-pharmaceuticals/) CNBX - [LianBio](https://aibio.space/companies/lianbio/) LIANY - [Enzolytics](https://aibio.space/companies/enzolytics/) ENZC - [SQZ Biotechnologies](https://aibio.space/companies/sqz-biotechnologies/) SQZB - [Aditxt](https://aibio.space/companies/aditxt/) ADTX - [RISING BIOSCIENCES INC](https://aibio.space/companies/rising-biosciences/) RBII ## VIVOS INC annual financials | Line | FY2025 | FY2024 | |---|---|---| | Revenue | | [$4,995](https://www.sec.gov/Archives/edgar/data/1449349/000164117225000238/) | | Research and development | [$352,232](https://www.sec.gov/Archives/edgar/data/1449349/000149315226013701/) | [$324,629](https://www.sec.gov/Archives/edgar/data/1449349/000149315226013701/) | | Net income (loss) | [-$3.1 million](https://www.sec.gov/Archives/edgar/data/1449349/000149315226013701/) | [-$2.9 million](https://www.sec.gov/Archives/edgar/data/1449349/000149315226013701/) | | Cash from operations | [-$2.1 million](https://www.sec.gov/Archives/edgar/data/1449349/000149315226013701/) | [-$1.7 million](https://www.sec.gov/Archives/edgar/data/1449349/000149315226013701/) | | Cash and equivalents | | [$2.2 million](https://www.sec.gov/Archives/edgar/data/1449349/000164117225000238/) | Latest balance sheet, Mar 31, 2025 (10-Q): cash and equivalents $3.3 million. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about VIVOS INC What is the ticker symbol of VIVOS INC? VIVOS INC trades under the ticker RDGL on OTC. Where is VIVOS INC listed? VIVOS INC is listed on OTC. Which country or territory is VIVOS INC listed under? Our directory records VIVOS INC under United States. Does aibio.space cover VIVOS INC? aibio.space lists VIVOS INC among 2,820 public biotech companies and publishes its news here as stories appear. Is VIVOS INC profitable? VIVOS INC reported a net loss of $3.1 million for the fiscal year ended Dec 31, 2025, and used $2.1 million of cash in operations, per its annual report to the SEC. How much does VIVOS INC spend on research and development? $352,232 in the fiscal year ended Dec 31, 2025, per its annual report. How much cash does VIVOS INC have? $3.3 million in cash at Mar 31, 2025, per its 10-Q. ## Investor discussion: VIVOS INC Members talk about VIVOS INC (RDGL). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open OTC:RDGL on TradingView](https://www.tradingview.com/symbols/OTC-RDGL/). ## Listing details VIVOS INC is a public biotech or pharmaceutical company listed on OTC under the ticker RDGL, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: VIVOS INC - **Ticker**: RDGL - **Listing**: OTC - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/vivos/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "VIVOS INC (RDGL) stock listing, news and investor profile", 2026-10-31, https://aibio.space/companies/vivos/